Browsing by Author Li, Peiqi
Showing results 1 to 2 of 2
Issue Date |
Title |
Author(s) |
Feb-2022 |
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial |
Zhou, Caicun;Wang, Ziping;Sun, Yuping;Cao, Lejie;Ma, Zhiyong;Wu, Rong;Yu, Yan;Yao, Wenxiu;Chang, Jianhua;Chen, Jianhua;Zhuang, Wu;Cui, Jiuwei;Chen, Xueqin;Lu, You;Shen, Hong;Wang, Jingru;Li, Peiqi;Qin, Mengmeng;Lu, Dongmei;Yang, Jason |
1-Jun-2022 |
Updated efficacy and safety results from a phase 1b study of the PD-1 antagonist CS1003 combined with lenvatinib (LEN) as first-line (1L) treatment in Chinese patients (pts) with unresectable hepatocellular carcinoma (uHCC). |
Shen, Lin;Guo, Ye;Zhang, Yanqiao;Li, Wei;Gong, Jifang;Li, Qun;Ma, Zhigang;Wang, Nanya;Su, Rila;Cai, Zhongheng;Guo, Rong;Li, Peiqi;Tse, Archie N. |